ELAVL1 and familial pancreatic carcinoma: Conversely, pancreatic cancer cells overexpressing HuR are more sensitive to gemcitabine compared to control cells [51] due to a stabilization of the deoxycytidine kinase (dCK) mRNA, encoding the enzyme that metabolizes and thereby activates gemcitabine.